BioNexus Gene Lab Corp. (BGLC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.32
-0.04 (-0.75%)
At close: Oct 03, 2025, 3:59 PM
5.29
-0.56%
Pre-market: Oct 06, 2025, 07:00 AM EDT

BioNexus Gene Lab Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-616.17K -623.33K -348.32K -1.35M 199.1K -103.76K 307.42K -2.61M -259.25K -69.07K -156.97K -77.4K -138.66K 17.07K 89.24K 295.32K 28.26K 338.74K
Depreciation & Amortization
41.73K 40.02K 43.02K 49.08K 31.46K 29.59K 29.66K 29.29K 24.61K 24.87K 26.06K 25.83K 26.88K 26.65K 26.52K 26.82K 39.83K 15.06K
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a -88.95K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
179.86K -407.65K 54.49K 14.82K -480.12K 55.57K -102.81K 94.13K 274.26K -441.69K 721.76K -221.85K -467.86K -281.43K -381.43K 87.31K -462.67K -338.93K
Other Non-Cash Items
-51.13K 70.02K -203.04K -158.02K -576.5K 33.1K -522.47K 1.57M 183.91K -44.32K -134.77K 53.81K 51.12K -3.45K 5.15K -1.04K 16.79K -9.27K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-112.34K -310.79K 438.56K -744 -326.33K 3.92K 12.44K 106.64K 26.91K -28K 740.15K 306.64K -135.3K -78.1K 362.1K -5.22K -990.02K -229.1K
Operating Cash Flow
-737.91K -824.07K -69.77K -1.46M -672.27K -37.15K -261.91K -899.35K -23.82K -116.52K 474.47K 308.89K -195.97K -37.84K 483.01K 315.87K -905.14K 115.43K
Capital Expenditures
-21.46K -9.05K -4.02K -199.19K -1.83K -21.95K -937 -134K -14.36K -102 -17.03K -3.66K -1.29K -32.19K -1.28K -410 -666 -807
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-15.7K -15.53K -85.4K -181.2K -110.27K -194.69K -24.62K -282.67K 202.00 -13.65K -113.73K 6.82K -232.62K -172.17K -83.55K -60.53K -75.73K -296.02K
Sales Maturities Of Investments
n/a n/a 574.04K 197.06K 86.33K 211.34K -708 26.85K n/a n/a n/a n/a n/a n/a -22 -52 n/a n/a
Other Investing Acitivies
8.63K 8.93K 9.54K 212.00 89.08K 8.95K 12.52K 29.1K 11.1K 8.69K 80.86K 15.2K 12.09K 7.23K 8.56K 2.42K 16.52K 1.01K
Investing Cash Flow
-28.53K -15.65K 494.16K -183.12K 63.31K 3.65K -13.75K -360.71K -3.06K -5.06K -49.9K 18.36K -221.82K -197.13K -76.29K -58.58K -59.88K -295.83K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -34.04K n/a -4.96K -6K -6.8K -8.55K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a -59.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.03K -860 205.77K -203.96K 175.41K 26.93K 11.12K -2.58K -2.43K -1.78K n/a -1.74K 150K n/a n/a -84 -1.84K n/a
Financial Cash Flow
-1.03K -860 146.59K -203.96K 175.41K 26.93K 11.12K 5.75M -2.43K -1.78K n/a -1.74K 115.96K n/a -4.96K -6.08K -8.63K -8.55K
Net Cash Flow
-552.25K -797.53K -1.25M -1.28M -476.49K -79.02K -217.55K 4.39M -214.53K -145.65K 656.6K 121.94K -503.99K -279.6K 423.52K 217.69K -991.95K -313.03K
Free Cash Flow
-759.37K -833.12K -73.79K -1.65M -674.11K -59.1K -262.85K -1.03M -38.18K -116.62K 457.44K 305.23K -197.26K -70.03K 481.73K 315.46K -905.81K 114.62K